Your browser doesn't support javascript.
loading
KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response.
Ager, Casey R; Zhang, Mingxuan; Chaimowitz, Matthew; Bansal, Shruti; Tagore, Somnath; Obradovic, Aleksandar; Jugler, Collin; Rogava, Meri; Melms, Johannes C; McCann, Patrick; Spina, Catherine; Drake, Charles G; Dallos, Matthew C; Izar, Benjamin.
  • Ager CR; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA ager.casey@mayo.edu bi2175@cumc.columbia.edu.
  • Zhang M; Department of Immunology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Chaimowitz M; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA.
  • Bansal S; Department of Urology, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
  • Tagore S; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Obradovic A; Department of Molecular Pathology and Therapeutics, Columbia University Irving Medical Center, New York, New York, USA.
  • Jugler C; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA.
  • Rogava M; Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Melms JC; Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA.
  • McCann P; Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Spina C; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Drake CG; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York, USA.
  • Dallos MC; Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, New York, USA.
  • Izar B; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York, USA.
J Immunother Cancer ; 11(9)2023 09.
Article en En | MEDLINE | ID: mdl-37657842

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article